Alpha-0261 - Shenzhen Alpha Molecular Technology
A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers (clinicaltrials.gov) - Dec 14, 2025 - P1 | N=60 | Recruiting | Sponsor: AlphaMol Science Ltd. (Shanghai) 
New P1 trial
http://clinicaltrials.gov/ct2/show/NCT07279636
 
Dec 14, 2025
 
Prev